Society of Nuclear Medicine and Molecular Imaging (SNMMI)

The Society of Nuclear Medicine and Molecular Imaging (SNMMI), formerly the Society of Nuclear Medicine, is a nonprofit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging (PET and SPECT). The bulk of nuclear imaging exams relate to oncology, about a third to cardiac imaging and the rest for a variety of protocols, including imaging inflammation and beta-amyloid plaques that cause Alzheimer's disease. 

RSS icon
SNMMI Image of the Year

SNMMI unveils Image of the Year

This year the Henry N. Wagner Jr., Image of the Year is actually a group of images displaying the efficacy of a 68Ga-DOTA-5G and 177Lu-DOTA-ABM-5G theranostic pairing that improves the detection and treatment of metastatic pancreatic cancer. 

whole-body pet scanner add-on device presented at #SNMMI 2023

New PET technology offers 'clear improvement' of whole-body scan resolution

The new technology achieves this by way of two add-on detectors that simultaneously scan patients during their whole-body PET exam.

Imaging advocacy group warns of supply shortage that’s having ‘profound negative impact’ on patient care

Radiologists took to Twitter to voice their frustrations over the worsening situation, while the manufacturer issued an update Thursday.   

New practice guidelines for PET imaging of neuroendocrine tumors

Issued by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM), the new guidelines are intended to inform any practitioners involved in ordering, performing, reading and reporting SSTR PET imaging.

FAPI PET/CT shows promise as a better radiotracer for cancer than 18F-FDG. It also can be used for detection of infection and inflammation.

VIDEO: 6 key advances in molecular imaging technology for PET and SPECT

Munir Ghesani, MD, President of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), system chief of nuclear medicine at Mount Sinai Health, explains recent advances in nuclear imaging technology.

Two examples of PSMA-PET scans showing numerous prostate cancer metastases spread throughout the body. Many of these smaller tumors would not have been dected on previous standard-of-care imaging. Photo on left courtesy of SNMMI, right University of Chicago. #PSMAPET

PSMA-PET is rapidly changing the standard of care for prostate cancer patients

Adoption of PSMA-PET has been swift because it can significantly improve prostate cancer detection and treatment. SNMMI President Munir Ghesani, MD, explains how.

Researchers have designed a new cardiac SPECT imaging system that could potentially deliver images much faster than current models. The team presented its findings at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), SNMMI 2022.

The need for speed: New-look cardiac SPECT imaging system could be up to 100 times faster than current models

Researchers presented their proposed design of a self-collimating SPECT system at SNMMI 2022.

Targeted radionuclide alpha therapy study wins SNMMI's Abstract of the Year

The study touts the benefits of targeted radionuclide alpha therapy for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) who have not had success with other treatments.

Displaying 1 - 8 of 43
Design by Adaptive Theme